Official registry condition

Poor Ovarian Response peptide trials

4 selected ClinicalTrials.gov records carrying the official condition label Poor Ovarian Response. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.

Registry records

4 selected records.

Connected peptides

2 profiles.

Registry update years

2013–2026 in selected records.

Indication intelligence

Selected evidence landscape

Connected profiles2

Exact peptide identities attached to retained registry observations carrying this condition label.

Trial phases2

Phase labels copied from the retained ClinicalTrials.gov versions.

Registry statuses2

Overall statuses at each retained observation, not necessarily current today.

Across the connected peptide profiles, PeptideScanner also carries 36 selected PubMed records and 12 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Poor Ovarian Response unless their own cited source says so.

Collection change ledger

Recently changed records on this condition hub

All recent changes →

These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.

Record added

ClinicalTrials.gov record NCT01732068

PeptideScanner retained ClinicalTrials.gov record NCT01732068 at 2026-11-15T21:49:16.513Z. Its registry update date was 2013-05-09, and PeptideScanner's reviewed identity mapping was triptorelin.

PeptideScanner change date
November 15, 2026
Cited source date
May 9, 2013
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01732094

PeptideScanner retained ClinicalTrials.gov record NCT01732094 at 2026-11-15T21:49:16.513Z. Its registry update date was 2013-05-09, and PeptideScanner's reviewed identity mapping was triptorelin.

PeptideScanner change date
November 15, 2026
Cited source date
May 9, 2013
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01816321

PeptideScanner retained ClinicalTrials.gov record NCT01816321 at 2026-11-15T22:03:26.540Z. Its registry update date was 2016-06-23, and PeptideScanner's reviewed identity mapping was ganirelix.

PeptideScanner change date
November 15, 2026
Cited source date
June 23, 2016
Evidence lane
Clinical trials

Attributed registry records

Selected records

All trial facets →